-+ 0.00%
-+ 0.00%
-+ 0.00%

Prestige Consumer Healthcare First Quarter 2026 Earnings: Misses Expectations

Simply Wall St·08/09/2025 13:52:46
Listen to the news
NYSE:PBH 1 Year Share Price vs Fair Value
NYSE:PBH 1 Year Share Price vs Fair Value
Explore Prestige Consumer Healthcare's Fair Values from the Community and select yours

Prestige Consumer Healthcare (NYSE:PBH) First Quarter 2026 Results

Key Financial Results

  • Revenue: US$249.5m (down 6.6% from 1Q 2025).
  • Net income: US$47.5m (down 3.3% from 1Q 2025).
  • Profit margin: 19% (in line with 1Q 2025).
  • EPS: US$0.96 (down from US$0.98 in 1Q 2025).
earnings-and-revenue-growth
NYSE:PBH Earnings and Revenue Growth August 9th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Prestige Consumer Healthcare Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 4.2%. Earnings per share (EPS) also missed analyst estimates by 3.1%.

Looking ahead, revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Pharmaceuticals industry in the US.

Performance of the American Pharmaceuticals industry.

The company's shares are down 11% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Prestige Consumer Healthcare that you should be aware of.